This meeting took place in 2015

Here are the related meetings in 2020:
Diabetes: Glucose Control and Beyond (J5)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Diabetes: New Insights into Molecular Mechanisms and Therapeutic Strategies (T2)

Organizer(s) Takashi Kadowaki, Juleen R. Zierath, Nobuya Inagaki and Barbara B. Kahn
October 25—29, 2015
Westin Miyako Kyoto • Kyoto, Japan
Discounted Abstract Deadline: Jun 25, 2015
Abstract Deadline: Jul 23, 2015
Scholarship Deadline: Jun 25, 2015
Discounted Registration Deadline: Aug 25, 2015

Lead Sponsor: Takeda Pharmaceutical Company Ltd. Other Sponsors: Astellas Pharma Inc., Journal of Molecular Cell Biology (JMCB), Novo Nordisk A/S and Sanofi-Aventis Deutschland GmbH

Summary of Meeting:
The prevalence of type 2 diabetes is rising to epidemic proportions worldwide. Type 2 diabetes is a complex disease caused by dysfunction of multiple organ systems, and disease susceptibility is profoundly influenced by both genetic and environmental factors. It is essential to bring leading professionals in the academic and pharmaceutical communities together with various specialties in diabetes research to share new approaches and research paradigms. The meeting will present the latest discoveries in diabetes research, highlighting essential aspects of diabetes, as well as emerging themes that are likely to provide novel therapeutic approaches. The major topics of the meetings are: Islet Dysfunction; Gut Biology and Systemic Metabolism; CNS Control of Metabolism; Adipocyte Biology; Insulin Resistance; Genetics and Epigenetics; Diabetes and Healthy Lifespan and Regenerative Medicine. The ultimate goal for the meeting is to provide a forum that encourages attendees to communicate and exchange ideas to facilitate an integrative understanding of pathogenesis and development of therapeutic strategies for prevention and treatment of diabetes.

View Meeting Program


Sanofi-Aventis Deutschland GmbH Scholarship Recipients

Tomohisa Aoyama
University of Tokyo, Japan

Yasmina Belarbi
Institutionen för Medicin, Sweden

Stephanie M. Correa
University of California, San Francisco, USA

Khanh V. Doan
Yonsei University Wonju College of Medicine, South Korea

Essi M. Havula
University of Helsinki and Institute of Biotechnology, Finland

Markus Jabs
German Cancer Research Center, Germany

Svetlana Keylin
University of California, San Francisco, USA

KyeongJin Kim
Columbia University, USA

Debora R. Sobreira
University of Chicago, USA

Qiong Wang
City of Hope/BRI, USA

C.K. Wong
University of British Columbia, Canada

Yibo Wu
RIKEN Center for Integrative Medical Sciences, Japan